Why Jaguar Health (JAGX) Stock Is Down 15%
Portfolio Pulse from Henry Khederian
Jaguar Health Inc (NASDAQ:JAGX) shares dropped 10% to $1.08 after reporting worse-than-expected Q2 results. The company posted a loss of $4.04 per share, missing the analyst estimate of a $1.11 loss. Sales were $2.72 million, below the $3.94 million estimate but up 1.6% year-over-year. Despite some operational improvements, the stock's performance reflects investor disappointment.
August 13, 2024 | 3:15 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Jaguar Health shares fell 10% to $1.08 after the company reported a Q2 loss of $4.04 per share, significantly missing the analyst estimate of a $1.11 loss. Sales were also below expectations at $2.72 million, though up 1.6% year-over-year. Despite some operational improvements, the stock's decline reflects investor disappointment.
The significant miss on both earnings and sales estimates has led to a sharp decline in the stock price. Despite some operational improvements, the market's reaction indicates a lack of confidence in the company's short-term performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100